Provided by Tiger Fintech (Singapore) Pte. Ltd.

AIM ImmunoTech

0.0949
0.0000
Volume:- -
Turnover:- -
Market Cap:6.86M
PE:-0.31
High:0.0949
Open:0.0949
Low:0.0949
Close:0.0949
Loading ...

Unicorn AIM VCT’s Subscription Offer Oversubscribed

TIPRANKS
·
31 Mar

Octopus AIM VCT 2 Announces New Share Issuance and Trading Plans

TIPRANKS
·
27 Mar

Octopus AIM VCT Announces New Share Issuance and Voting Rights Update

TIPRANKS
·
27 Mar

BRIEF-AIM Immunotech Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Corporate Update

Reuters
·
27 Mar

AIM ImmunoTech made ‘significant strides’ over course of 2024

TIPRANKS
·
27 Mar

AIM ImmunoTech FY 2024 GAAP EPS $(0.31) Beats $(0.34) Estimate, Sales $170.000K Beat $145.000K Estimate

Benzinga
·
27 Mar

AIM ImmunoTech Cash Position As Of Dec. 31 $4M

Benzinga
·
27 Mar

AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
27 Mar

Press Release: AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
27 Mar

ADVFN Shares Tumble on AIM Delisting Proposal

Dow Jones
·
27 Mar

ADVFN plc Announces Interim Results and Strategic Delisting from AIM

TIPRANKS
·
27 Mar

Celadon Pharmaceuticals to Delist From AIM

Dow Jones
·
24 Mar

AIM: Private equity takeovers reach £5bn over last year

cityam
·
24 Mar

AIM Gets US FDA Clinical Trial Approval for Herpes Zoster Vaccine; Shares Up 8%

MT Newswires Live
·
24 Mar

Wellnex Life Secures AIM Listing on London Stock Exchange

MT Newswires Live
·
24 Mar

Octopus AIM VCT 2 Announces Share Buyback and Voting Rights Update

TIPRANKS
·
21 Mar

AIM IPOs offer glimpse of recovery for junior stock exchange

cityam
·
17 Mar

U.K.'s MHA Plans IPO on London's AIM, Seeking to Raise Up to $162 Mln

Dow Jones
·
17 Mar

Wellnex Life Reports 89% Revenue Surge in Early 2025 as AIM Listing Nears

MT Newswires Live
·
17 Mar

AIM Vaccine Reports Significant Reduction in Annual Losses

TIPRANKS
·
17 Mar